Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy

Development and Validation of Nine Deprescribing Algorithms for Patients on Hemodialysis to Decrease Polypharmacy

Background: Polypharmacy is ubiquitous in patients on hemodialysis (HD), and increases risk of adverse events, medication interactions, nonadherence, and mortality. Appropriately applied deprescribing can potentially minimize polypharmacy risks. Existing guidelines are unsuitable for nephrology clin...

Full description

Bibliographic Details
Main Authors: Melissa J. Lefebvre, Patrick C. K. Ng, Arlene Desjarlais, Dennis McCann, Blair Waldvogel, Marcello Tonelli, Amit X. Garg, Jo-Anne Wilson, Monica Beaulieu, Judith Marin, Cali Orsulak, Anita Lloyd, Caitlin McIntyre, Jordanne Feldberg, Clara Bohm, Marisa Battistella
Format: Article
Language:English
Published: SAGE Publishing 2020-10-01
Series:Canadian Journal of Kidney Health and Disease
Online Access:https://doi.org/10.1177/2054358120968674

Similar Items

Similar Items